Table 3.
Univariable | Multivariable* | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age ≥65 (at listing) | 1.39 | 1.33–1.45 | <0.001 | 1.50 | 1.41 – 1.60 | <0.001 |
HCC | 1.13 | 1.09–1.18 | <0.001 | 1.26 | 1.18 – 1.33 | <0.001 |
Female gender | 0.93 | 0.90–0.96 | <0.001 | |||
Liver diagnosis | ||||||
Alcohol | Ref | Ref | ||||
Hepatitis C | 1.26 | 1.21–1.32 | <0.001 | 1.34 | 1.28 – 1.40 | <0.001 |
NASH | 1.06 | 1.01–1.12 | 0.02 | 1.07 | 1.01 – 1.12 | 0.02 |
Autoimmune | 0.81 | 0.77–0.86 | <0.001 | 0.87 | 0.81 – 0.93 | <0.001 |
Other | 1.10 | 1.02–1.17 | 0.007 | 1.11 | 1.04 – 1.18 | 0.001 |
MELD (final) per point | 1.01 | 1.01–1.01 | <0.001 | 1.01 | 1.01 – 1.02 | <0.001 |
Waiting List Time per 90 days | 0.99 | 0.98 – 0.99 | <0.001 | 0.99 | 0.98 – 0.997 | 0.03 |
KPS per 10 points | 1.00 | 0.00–1.00 | <0.001 | 0.96 | 0.95 – 0.97 | <0.001 |
Hepatic encephalopathy | 1.21 | 1.16–1.26 | <0.001 | 1.11 | 1.05 – 1.18 | <0.001 |
Donor risk index per 0.1 points | 1.38 | 1.30–1.47 | <0.001 | 1.03 | 1.03 – 1.04 | <0.001 |
HR, hazard ratio; CI, confidence interval; HCC, hepatocellular carcinoma; NASH, nonalcoholic steatohepatitis; MELD, model for end stage liver disease; KPS, Karnofsky Performance Status
Multivariable model also adjusted for interaction term between age and HCC